Global Companion Diagnostics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Companion Diagnostics Market Size 2017-2028

2.1.2 Companion Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Companion Diagnostics Segment by Type

2.2.1 Polymerase Chain Reaction (PCR)

2.2.2 Immunohistochemistry (IHC)

2.2.3 In Situ Hybridization (ISH)

2.2.4 Next Generation Sequencing (NGS)

2.3 Companion Diagnostics Market Size by Type

2.3.1 Companion Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Companion Diagnostics Market Size Market Share by Type (2017-2022)

2.4 Companion Diagnostics Segment by Application

2.4.1 Hospitals

2.4.2 Pharmaceutical Companies

2.4.3 Laboratories

2.4.4 Other

2.5 Companion Diagnostics Market Size by Application

2.5.1 Companion Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Companion Diagnostics Market Size Market Share by Application (2017-2022)

3 Companion Diagnostics Market Size by Player

3.1 Companion Diagnostics Market Size Market Share by Players

3.1.1 Global Companion Diagnostics Revenue by Players (2020-2022)

3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2020-2022)

3.2 Global Companion Diagnostics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Companion Diagnostics by Regions

4.1 Companion Diagnostics Market Size by Regions (2017-2022)

4.2 Americas Companion Diagnostics Market Size Growth (2017-2022)

4.3 APAC Companion Diagnostics Market Size Growth (2017-2022)

4.4 Europe Companion Diagnostics Market Size Growth (2017-2022)

4.5 Middle East & Africa Companion Diagnostics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Companion Diagnostics Market Size by Country (2017-2022)

5.2 Americas Companion Diagnostics Market Size by Type (2017-2022)

5.3 Americas Companion Diagnostics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Companion Diagnostics Market Size by Region (2017-2022)

6.2 APAC Companion Diagnostics Market Size by Type (2017-2022)

6.3 APAC Companion Diagnostics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Companion Diagnostics by Country (2017-2022)

7.2 Europe Companion Diagnostics Market Size by Type (2017-2022)

7.3 Europe Companion Diagnostics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Companion Diagnostics by Region (2017-2022)

8.2 Middle East & Africa Companion Diagnostics Market Size by Type (2017-2022)

8.3 Middle East & Africa Companion Diagnostics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Companion Diagnostics Market Forecast

10.1 Global Companion Diagnostics Forecast by Regions (2023-2028)

10.1.1 Global Companion Diagnostics Forecast by Regions (2023-2028)

10.1.2 Americas Companion Diagnostics Forecast

10.1.3 APAC Companion Diagnostics Forecast

10.1.4 Europe Companion Diagnostics Forecast

10.1.5 Middle East & Africa Companion Diagnostics Forecast

10.2 Americas Companion Diagnostics Forecast by Country (2023-2028)

10.2.1 United States Companion Diagnostics Market Forecast

10.2.2 Canada Companion Diagnostics Market Forecast

10.2.3 Mexico Companion Diagnostics Market Forecast

10.2.4 Brazil Companion Diagnostics Market Forecast

10.3 APAC Companion Diagnostics Forecast by Region (2023-2028)

10.3.1 China Companion Diagnostics Market Forecast

10.3.2 Japan Companion Diagnostics Market Forecast

10.3.3 Korea Companion Diagnostics Market Forecast

10.3.4 Southeast Asia Companion Diagnostics Market Forecast

10.3.5 India Companion Diagnostics Market Forecast

10.3.6 Australia Companion Diagnostics Market Forecast

10.4 Europe Companion Diagnostics Forecast by Country (2023-2028)

10.4.1 Germany Companion Diagnostics Market Forecast

10.4.2 France Companion Diagnostics Market Forecast

10.4.3 UK Companion Diagnostics Market Forecast

10.4.4 Italy Companion Diagnostics Market Forecast

10.4.5 Russia Companion Diagnostics Market Forecast

10.5 Middle East & Africa Companion Diagnostics Forecast by Region (2023-2028)

10.5.1 Egypt Companion Diagnostics Market Forecast

10.5.2 South Africa Companion Diagnostics Market Forecast

10.5.3 Israel Companion Diagnostics Market Forecast

10.5.4 Turkey Companion Diagnostics Market Forecast

10.5.5 GCC Countries Companion Diagnostics Market Forecast

10.6 Global Companion Diagnostics Forecast by Type (2023-2028)

10.7 Global Companion Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche Holdings

11.1.1 Roche Holdings Company Information

11.1.2 Roche Holdings Companion Diagnostics Product Offered

11.1.3 Roche Holdings Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche Holdings Main Business Overview

11.1.5 Roche Holdings Latest Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Information

11.2.2 Abbott Laboratories Companion Diagnostics Product Offered

11.2.3 Abbott Laboratories Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Abbott Laboratories Main Business Overview

11.2.5 Abbott Laboratories Latest Developments

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Information

11.3.2 Thermo Fisher Scientific Companion Diagnostics Product Offered

11.3.3 Thermo Fisher Scientific Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Thermo Fisher Scientific Main Business Overview

11.3.5 Thermo Fisher Scientific Latest Developments

11.4 Agilent Technologies

11.4.1 Agilent Technologies Company Information

11.4.2 Agilent Technologies Companion Diagnostics Product Offered

11.4.3 Agilent Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Agilent Technologies Main Business Overview

11.4.5 Agilent Technologies Latest Developments

11.5 Life Technologies

11.5.1 Life Technologies Company Information

11.5.2 Life Technologies Companion Diagnostics Product Offered

11.5.3 Life Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Life Technologies Main Business Overview

11.5.5 Life Technologies Latest Developments

11.6 GE Healthcare

11.6.1 GE Healthcare Company Information

11.6.2 GE Healthcare Companion Diagnostics Product Offered

11.6.3 GE Healthcare Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 GE Healthcare Main Business Overview

11.6.5 GE Healthcare Latest Developments

11.7 Agendia

11.7.1 Agendia Company Information

11.7.2 Agendia Companion Diagnostics Product Offered

11.7.3 Agendia Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Agendia Main Business Overview

11.7.5 Agendia Latest Developments

11.8 Qiagen

11.8.1 Qiagen Company Information

11.8.2 Qiagen Companion Diagnostics Product Offered

11.8.3 Qiagen Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Qiagen Main Business Overview

11.8.5 Qiagen Latest Developments

11.9 Genomic Health

11.9.1 Genomic Health Company Information

11.9.2 Genomic Health Companion Diagnostics Product Offered

11.9.3 Genomic Health Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Genomic Health Main Business Overview

11.9.5 Genomic Health Latest Developments

11.10 Myriad Genetics

11.10.1 Myriad Genetics Company Information

11.10.2 Myriad Genetics Companion Diagnostics Product Offered

11.10.3 Myriad Genetics Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Myriad Genetics Main Business Overview

11.10.5 Myriad Genetics Latest Developments

11.11 Advanced Cell Diagnostics

11.11.1 Advanced Cell Diagnostics Company Information

11.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Offered

11.11.3 Advanced Cell Diagnostics Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Advanced Cell Diagnostics Main Business Overview

11.11.5 Advanced Cell Diagnostics Latest Developments

11.12 Danaher

11.12.1 Danaher Company Information

11.12.2 Danaher Companion Diagnostics Product Offered

11.12.3 Danaher Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Danaher Main Business Overview

11.12.5 Danaher Latest Developments

11.13 Applied Proteomics

11.13.1 Applied Proteomics Company Information

11.13.2 Applied Proteomics Companion Diagnostics Product Offered

11.13.3 Applied Proteomics Companion Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Applied Proteomics Main Business Overview

11.13.5 Applied Proteomics Latest Developments

12 Research Findings and Conclusion

Table 1. Companion Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Polymerase Chain Reaction (PCR)

Table 3. Major Players of Immunohistochemistry (IHC)

Table 4. Major Players of In Situ Hybridization (ISH)

Table 5. Major Players of Next Generation Sequencing (NGS)

Table 6. Companion Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Companion Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Companion Diagnostics Market Size Market Share by Type (2017-2022)

Table 9. Companion Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Companion Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Companion Diagnostics Market Size Market Share by Application (2017-2022)

Table 12. Global Companion Diagnostics Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Companion Diagnostics Revenue Market Share by Player (2020-2022)

Table 14. Companion Diagnostics Key Players Head office and Products Offered

Table 15. Companion Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Companion Diagnostics Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Companion Diagnostics Market Size Market Share by Regions (2017-2022)

Table 20. Americas Companion Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Companion Diagnostics Market Size Market Share by Country (2017-2022)

Table 22. Americas Companion Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Companion Diagnostics Market Size Market Share by Type (2017-2022)

Table 24. Americas Companion Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Companion Diagnostics Market Size Market Share by Application (2017-2022)

Table 26. APAC Companion Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Companion Diagnostics Market Size Market Share by Region (2017-2022)

Table 28. APAC Companion Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Companion Diagnostics Market Size Market Share by Type (2017-2022)

Table 30. APAC Companion Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Companion Diagnostics Market Size Market Share by Application (2017-2022)

Table 32. Europe Companion Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Companion Diagnostics Market Size Market Share by Country (2017-2022)

Table 34. Europe Companion Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Companion Diagnostics Market Size Market Share by Type (2017-2022)

Table 36. Europe Companion Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Companion Diagnostics Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Companion Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Companion Diagnostics Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Companion Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Companion Diagnostics Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Companion Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Companion Diagnostics Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Companion Diagnostics

Table 45. Key Market Challenges & Risks of Companion Diagnostics

Table 46. Key Industry Trends of Companion Diagnostics

Table 47. Global Companion Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Companion Diagnostics Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Companion Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Companion Diagnostics Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Companion Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Companion Diagnostics Market Size Market Share Forecast by Application (2023-2028)

Table 53. Roche Holdings Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 54. Roche Holdings Companion Diagnostics Product Offered

Table 55. Roche Holdings Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Roche Holdings Main Business

Table 57. Roche Holdings Latest Developments

Table 58. Abbott Laboratories Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 59. Abbott Laboratories Companion Diagnostics Product Offered

Table 60. Abbott Laboratories Main Business

Table 61. Abbott Laboratories Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Abbott Laboratories Latest Developments

Table 63. Thermo Fisher Scientific Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 64. Thermo Fisher Scientific Companion Diagnostics Product Offered

Table 65. Thermo Fisher Scientific Main Business

Table 66. Thermo Fisher Scientific Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Thermo Fisher Scientific Latest Developments

Table 68. Agilent Technologies Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 69. Agilent Technologies Companion Diagnostics Product Offered

Table 70. Agilent Technologies Main Business

Table 71. Agilent Technologies Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Agilent Technologies Latest Developments

Table 73. Life Technologies Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 74. Life Technologies Companion Diagnostics Product Offered

Table 75. Life Technologies Main Business

Table 76. Life Technologies Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Life Technologies Latest Developments

Table 78. GE Healthcare Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 79. GE Healthcare Companion Diagnostics Product Offered

Table 80. GE Healthcare Main Business

Table 81. GE Healthcare Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. GE Healthcare Latest Developments

Table 83. Agendia Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 84. Agendia Companion Diagnostics Product Offered

Table 85. Agendia Main Business

Table 86. Agendia Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Agendia Latest Developments

Table 88. Qiagen Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 89. Qiagen Companion Diagnostics Product Offered

Table 90. Qiagen Main Business

Table 91. Qiagen Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Qiagen Latest Developments

Table 93. Genomic Health Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 94. Genomic Health Companion Diagnostics Product Offered

Table 95. Genomic Health Main Business

Table 96. Genomic Health Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Genomic Health Latest Developments

Table 98. Myriad Genetics Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 99. Myriad Genetics Companion Diagnostics Product Offered

Table 100. Myriad Genetics Main Business

Table 101. Myriad Genetics Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Myriad Genetics Latest Developments

Table 103. Advanced Cell Diagnostics Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 104. Advanced Cell Diagnostics Companion Diagnostics Product Offered

Table 105. Advanced Cell Diagnostics Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Advanced Cell Diagnostics Main Business

Table 107. Advanced Cell Diagnostics Latest Developments

Table 108. Danaher Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 109. Danaher Companion Diagnostics Product Offered

Table 110. Danaher Main Business

Table 111. Danaher Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Danaher Latest Developments

Table 113. Applied Proteomics Details, Company Type, Companion Diagnostics Area Served and Its Competitors

Table 114. Applied Proteomics Companion Diagnostics Product Offered

Table 115. Applied Proteomics Main Business

Table 116. Applied Proteomics Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Applied Proteomics Latest Developments

List of Figures

Figure 1. Companion Diagnostics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Companion Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Companion Diagnostics Market Size Market Share by Type in 2021

Figure 7. Companion Diagnostics in Hospitals

Figure 8. Global Companion Diagnostics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Companion Diagnostics in Pharmaceutical Companies

Figure 10. Global Companion Diagnostics Market: Pharmaceutical Companies (2017-2022) & ($ Millions)

Figure 11. Companion Diagnostics in Laboratories

Figure 12. Global Companion Diagnostics Market: Laboratories (2017-2022) & ($ Millions)

Figure 13. Companion Diagnostics in Other

Figure 14. Global Companion Diagnostics Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Companion Diagnostics Market Size Market Share by Application in 2021

Figure 16. Global Companion Diagnostics Revenue Market Share by Player in 2021

Figure 17. Global Companion Diagnostics Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Companion Diagnostics Market Size 2017-2022 ($ Millions)

Figure 19. APAC Companion Diagnostics Market Size 2017-2022 ($ Millions)

Figure 20. Europe Companion Diagnostics Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Companion Diagnostics Market Size 2017-2022 ($ Millions)

Figure 22. Americas Companion Diagnostics Value Market Share by Country in 2021

Figure 23. Americas Companion Diagnostics Consumption Market Share by Type in 2021

Figure 24. Americas Companion Diagnostics Market Size Market Share by Application in 2021

Figure 25. United States Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Companion Diagnostics Market Size Market Share by Region in 2021

Figure 30. APAC Companion Diagnostics Market Size Market Share by Application in 2021

Figure 31. China Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Companion Diagnostics Market Size Market Share by Country in 2021

Figure 38. Europe Companion Diagnostics Market Size Market Share by Type in 2021

Figure 39. Europe Companion Diagnostics Market Size Market Share by Application in 2021

Figure 40. Germany Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Companion Diagnostics Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Companion Diagnostics Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Companion Diagnostics Market Size Market Share by Application in 2021

Figure 48. Egypt Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Companion Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 54. APAC Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 55. Europe Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 57. United States Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 58. Canada Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 61. China Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 62. Japan Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 63. Korea Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 65. India Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 66. Australia Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 67. Germany Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 68. France Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 69. UK Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 70. Italy Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 71. Russia Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 72. Spain Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 75. Israel Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Companion Diagnostics Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Companion Diagnostics Market Size 2023-2028 ($ Millions)